Contraception and reproductive planning during the COVID-19 pandemic.
COVID-19
Contraception
SARS-CoV-2
coronavirus
family planning
reproductive health
Journal
Expert review of clinical pharmacology
ISSN: 1751-2441
Titre abrégé: Expert Rev Clin Pharmacol
Pays: England
ID NLM: 101278296
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
pubmed:
17
6
2020
medline:
5
8
2020
entrez:
16
6
2020
Statut:
ppublish
Résumé
The coronavirus disease (COVID-19) is a global health emergency. Major disruption to healthcare services during the current COVID-19 pandemic will last even after its peak. Sexual and reproductive health (SRH), specially contraception, needs to be understood as an essential service. This paper is a narrative review. Data from PubMed/MEDLINE, Scopus, and websites of scientific societies were screened during the months of April and May 2020. It addresses the main aspects related to contraception during the COVID-19 pandemic, with special emphasis on family planning services, extended use of long-acting reversible contraceptive (LARC) methods, drug interactions, and thromboembolism risk. We also specified some issues focused on the Brazilian reality. Ensuring proper contraception use in the COVID-19 time is very important. We encourage women, healthcare providers, policymakers, and the society to consider SRH services as priority.
Identifiants
pubmed: 32538185
doi: 10.1080/17512433.2020.1782738
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM